Measuring Adherence by Visual Inspection of Returned Empty Gel Applicators in the CAPRISA 004 Microbicide Trial

被引:0
|
作者
Tanuja N. Gengiah
Leila E. Mansoor
Michele Upfold
Anushka Naidoo
Nonhlanhla Yende-Zuma
Angela D. M. Kashuba
Quarraisha Abdool Karim
Salim S. Abdool Karim
机构
[1] University of KwaZulu-Natal,Centre for the AIDS Programme of Research in South Africa (CAPRISA), Doris Duke Medical Research Institute (2nd Floor)
[2] University of North Carolina at Chapel Hill,Clinical Pharmacology and Analytical Chemistry Core, UNC Center for AIDS Research, Eshelman School of Pharmacy
[3] Columbia University,Department of Epidemiology, Mailman School of Public Health
来源
AIDS and Behavior | 2014年 / 18卷
关键词
Adherence; Visual inspection; Returned applicators; Microbicides;
D O I
暂无
中图分类号
学科分类号
摘要
In the CAPRISA 004 trial, adherence was estimated as the proportion of reported sex acts covered by two gel doses, which was assessed by counting returned empty gel applicators. The returned empty applicators were inspected visually in a standardized manner for residue on the outside of the applicator, as an indicator of vaginal insertion. Over 15 months, spanning 11,839 study visits by 838 women, a total of 59,800 returned empty applicators were inspected. By visual assessment, 77.5 % of these applicators appeared to have been inserted. To test the accuracy of the assessment we fitted a Cox model and found that the risk for HIV infection was doubled when less than half of the returned empty applicators had been assessed as not inserted in the vagina. Visual inspection enhanced both the accuracy of the adherence measurement and aided identification of mechanical problems with applicator use experienced by women in the trial.
引用
收藏
页码:820 / 825
页数:5
相关论文
共 42 条
  • [21] Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004)
    Burgers, W. A.
    Muller, T. L.
    Kiravu, A.
    Naranbhai, V.
    Sibeko, S.
    Werner, L.
    Karim, Q. Abdool
    Karim, S. S. Abdool
    RETROVIROLOGY, 2012, 9
  • [22] Preservation HIV-1-Specific IFNγ+CD4+T-Cell Responses in Breakthrough Infections After Exposure to Tenofovir Gel in the CAPRISA 004 Microbicide Trial
    Mureithi, Marianne W.
    Poole, Danielle
    Naranbhai, Vivek
    Reddy, Shabashini
    Mkhwanazi, Nompumelelo P.
    Sibeko, Sengeziwe
    Werner, Lise
    Karim, Quarraisha Abdool
    Karim, Salim Abdool
    Ndung'u, Thumbi
    Altfeld, Marcus
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (02) : 124 - 127
  • [23] Reply to 'Declining adherence as a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial'
    O'Hagan, Justin J.
    Hernan, Miguel A.
    Walensky, Rochelle P.
    Lipsitch, Marc
    AIDS, 2012, 26 (17) : 2262 - 2263
  • [24] Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial
    Matthews, Lynn T.
    Sibeko, Sengeziwe
    Mansoor, Leila E.
    Yende-Zuma, Nonhlanhla
    Bangsberg, David R.
    Karim, Quarraisha Abdool
    PLOS ONE, 2013, 8 (03):
  • [25] Co-enrollment in multiple HIV prevention trials - Experiences from the CAPRISA 004 Tenofovir gel trial
    Karim, Quarraisha Abdool
    Kharsany, Ayesha B. M.
    Naidoo, Kasavan
    Yende, Nonhlanhla
    Gengiah, Tanuja
    Omar, Zaheen
    Arulappan, Natasha
    Mlisana, Koleka P.
    Luthuli, Londiwe R.
    Karim, Salim S. Abdool
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 333 - 338
  • [26] Motivating, Measuring and Monitoring Adherence in the FACTS 001 Tenofovir Gel Microbicide Study
    Mudhune, Sandra
    Delany-Moretlwe, Sinead
    Baron, Deborah
    Pato, Sinazo
    Stadler, Jonathan
    Ngcobo, Nkosinathi
    Khunwane, Mamakiri
    Makgopa, Sylvia
    Malefo, Matshidiso
    Ntjana, Hilda
    Nkompela, T.
    Sibisi, Gugu
    Ikaneng, T.
    Seemise, K.
    Mdanda, Sanele
    Manenzhe, K.
    Morolo, M.
    Gray, Glenda
    Rees, Helen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A169 - A169
  • [27] HIV Disease Progression in Seroconvertors from the CAPRISA 004 Tenofovir Gel Pre-exposure Prophylaxis Trial
    Garrett, Nigel J.
    Werner, Lise
    Naicker, Nivashnee
    Naranbhai, Vivek
    Sibeko, Sengeziwe
    Samsunder, Natasha
    Gray, Clive
    Williamson, Carolyn
    Morris, Lynn
    Abdool-Karim, Quarraisha
    Abdool-Karim, Salim S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (01) : 55 - 61
  • [28] No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial
    Chopera, Denis R.
    Mann, Jaclyn K.
    Mwimanzi, Philip
    Omarjee, Saleha
    Kuang, Xiaomei T.
    Ndabambi, Nonkululeko
    Goodier, Sarah
    Martin, Eric
    Naranbhai, Vivek
    Karim, Salim Abdool
    Karim, Quarraisha Abdool
    Brumme, Zabrina L.
    Ndung'u, Thumbi
    Williamson, Carolyn
    Brockman, Mark A.
    PLOS ONE, 2013, 8 (08):
  • [29] Effects of Partnership Change on Microbicide Gel Adherence in a Clinical Trial (HPTN 035)
    Pamina M. Gorbach
    Clifton W. Kelly
    Joleen A. Borgerding
    Gita Ramjee
    Tchangani Tembo
    Newton Kumwenda
    Petina Musara
    Sarah Roberts
    Lisa Maslankowski
    AIDS and Behavior, 2014, 18 : 855 - 861
  • [30] Effects of Partnership Change on Microbicide Gel Adherence in a Clinical Trial (HPTN 035)
    Gorbach, Pamina M.
    Kelly, Clifton W.
    Borgerding, Joleen A.
    Ramjee, Gita
    Tembo, Tchangani
    Kumwenda, Newton
    Musara, Petina
    Roberts, Sarah
    Maslankowski, Lisa
    AIDS AND BEHAVIOR, 2014, 18 (05) : 855 - 861